Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Vascular Spasm01:16

Vascular Spasm

1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, performance, and remote programming utilization of an insertable cardiac monitor: The LUX-Dx PERFORM study.

Heart rhythm O2·2026
Same author

Frequent Droughts Reduce Carbon Stabilisation in Organo-Mineral Soils.

Global change biology·2026
Same author

Algorithm Improvements in an Insertable Cardiac Monitor Reduce False Positives and Episode Review Burden.

Pacing and clinical electrophysiology : PACE·2025
Same author

KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation.

Cell reports·2025
Same author

Adapting "Listen N Talk": Developing a Personalized Communication App with Culturally and Linguistically Diverse Residents in Aged Care.

Clinical interventions in aging·2025
Same author

Correction: Neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions.

Angiogenesis·2025
Same journal

Publisher Correction: Genome-wide association study of coronary flow reserve assessed by cardiac perfusion PET suggests a role for NF-κB pathway.

Nature cardiovascular research·2026
Same journal

Depth of neutrophil mobilization stratifies survival in ST-elevation myocardial infarction.

Nature cardiovascular research·2026
Same journal

Loss of STMP1 impairs mitochondrial structure and links inflammaging to heart failure.

Nature cardiovascular research·2026
Same journal

HeartMap charts new territory in cardiac disease biology.

Nature cardiovascular research·2026
Same journal

An integrated cell atlas of 2.4 million cardiac cells across 209 individuals in health and disease.

Nature cardiovascular research·2026
Same journal

Interim results of the Heart-2 clinical trial testing the safety and efficacy of VERVE-102 therapy.

Nature cardiovascular research·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay
08:43

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay

Published on: June 19, 2018

14.8K

Targeting VEGF-induced vascular permeability

Mark Richards1, Lena Claesson-Welsh2

  • 1Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. mark.richards@igp.uu.se.

Nature Cardiovascular Research
|August 28, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.7K
In Vivo Vascular Permeability Detection in Mouse Submandibular Gland
07:10

In Vivo Vascular Permeability Detection in Mouse Submandibular Gland

Published on: August 4, 2022

1.9K

Related Experiment Videos

Last Updated: Jun 15, 2025

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay
08:43

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay

Published on: June 19, 2018

14.8K
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.7K
In Vivo Vascular Permeability Detection in Mouse Submandibular Gland
07:10

In Vivo Vascular Permeability Detection in Mouse Submandibular Gland

Published on: August 4, 2022

1.9K